Presentation is loading. Please wait.

Presentation is loading. Please wait.

Bruno Hansen Bruno Hansen DG XII - Life Sciences - Coordination Fifth Framework Programme for Research, Technological Development and Demonstration 1998-2002.

Similar presentations


Presentation on theme: "Bruno Hansen Bruno Hansen DG XII - Life Sciences - Coordination Fifth Framework Programme for Research, Technological Development and Demonstration 1998-2002."— Presentation transcript:

1 Bruno Hansen Bruno Hansen DG XII - Life Sciences - Coordination Fifth Framework Programme for Research, Technological Development and Demonstration 1998-2002 Quality of Life and Management of Living Resources

2 DG XII - Life Sciences - Coordination 2 Life Sciences and Technologies Biotechnology Agriculture and Fisheries Biomedicine Science-driven approach From FP IV RDT Generic activities Support for infrastructure Key actions Societys needs Problem-solving approach to FP V

3 DG XII - Life Sciences - Coordination 3 Extrapolating from achievements Capitalising on European scientific strengths plant biotechnology, neurosciences, immunology, gene function, nutrition, etc. Building on strong EU networks Universities, Research centers, Industry, Consumers, Regulators Industry platforms and other dissemination channels LABIP, YIP, ACTIP, FLAIR-FLOW, NF-AIRID,... Training over 1000 trainees in the past 10 years Technology stimulation in SMEs emerging biotech industries / myriad of traditional food SMEs

4 DG XII - Life Sciences - Coordination 4 A break with the past The Fifth Framework Programme 1998 - 2002

5 DG XII - Life Sciences - Coordination 5 Societal Needs Quality of Life

6 DG XII - Life Sciences - Coordination 6 Societal Needs Quality of Life Food healthier foods improved food safety and quality new and improved food processes

7 DG XII - Life Sciences - Coordination 7 Societal Needs Quality of Life Food healthier foods improved food safety and quality new and improved food processes Health disease prevention and treatment healthy environment and working conditions reduced healthcare costs

8 DG XII - Life Sciences - Coordination 8 Societal Needs Quality of Life Food healthier foods improved food safety and quality new and improved food processes Health disease prevention and treatment healthy environment and working conditions reduced healthcare costs Environment cleaner bio-processes sustainable use of land and sea resources a clean environment

9 DG XII - Life Sciences - Coordination 9 Societal Needs Quality of Life Food healthier foods improved food safety and quality new and improved food processes Health disease prevention and treatment healthy environment and working conditions reduced healthcare costs Environment cleaner bio-processes sustainable use of land and sea resources a clean environment Employment entrepreneurship - job creation education, training and mobility integrated regional development

10 DG XII - Life Sciences - Coordination 10 Programme structure and budgetary distribution (i) 6 Key Actions : M EURO - Food, nutrition & health 290 - Control of infectious diseases300 - The cell factory400 - Environment and health 160 - Sustainable agriculture, fisheries and forestry, and integrated development of rural areas including mountain areas 520 - The ageing population and disabilities190 (ii) RTD activities of a generic nature 483 (iii) Support for research infrastructures 70

11 DG XII - Life Sciences - Coordination 11 KEY ACTIONS addressing explicitly formulated economic and social objectives of a European nature with a problem-solving approach aimed at mobilising the resources of various relevant disciplines, technologies and know-how using the whole range of activities, ranging from basic research to development and demonstration prepared and implemented in close consultation with the scientific community, industry and all relevant research end-users

12 DG XII - Life Sciences - Coordination 12 KEY ACTIONS EUROPEAN CHALLENGES SELECTED ISSUES ANTICIPATED DELIVERABLES RTD RESOURCES TO BE MOBILIZED

13 DG XII - Life Sciences - Coordination 13 Key action II: Control of infectious diseases RTD objectives development of improved or novel vaccines, especially against viral diseases, including support of clinical trials new / improved strategies to identify and control infectious diseases, directed at treatment & prevention public health and care-delivery systems, notably management, prevention and surveillance aspects Societal aims to combat established, emerging or re-emerging infectious diseases, both in humans and animals to improve quality of life through improved prevention and treatment to reduce healthcare costs to society

14 DG XII - Life Sciences - Coordination 14 RTD Activities of a Generic Nature & Support to Infrastructures Support for research Infrastructures Biological collections, Clinical research facilities, Facilities for aquaculture and fishery research, Pre-clinical research facilities, Biological information resources C hronic & degenerative (esp. cancer & diabetes), cardio-vascular diseases, and rare diseases. Research into the genome & diseases of genetic origin. Public health & health services research. Neurosciences. Biomedical ethics & bioethics Socio-economic aspects of life sciences & technologies Research relating to the disabled.

15 DG XII - Life Sciences - Coordination 15 Strategic aspects of implementation The emergence of a Biosociety and commensurate policy commitment 1.CONCENTRATION on strategic issues for the EU 2.FLEXIBILITY in programme and project management 3.TRANSPARENCY of the actors and means of action

16 DG XII - Life Sciences - Coordination 16 ROAD MAP: Principle Call for proposals Not open for submission

17 DG XII - Life Sciences - Coordination 17 Strategic aspects of implementation The emergence of a Biosociety and commensurate policy commitment 1.CONCENTRATION on strategic issues for the EU 2.FLEXIBILITY in programme and project management 3.TRANSPARENCY of the actors and means of action 4.COORDINATION with policies, actions, agencies and national R&D

18 DG XII - Life Sciences - Coordination 18 EAG1EAG2EAG3EAG4EAG5 INDUSTRIAL CHAMBER ACADEMIC CHAMBER PROBLEM-DRIVEN DEFINITIONS EAG1 Programme Management Committee (representatives of Member and Associated States) BUDGET - BASED KA 2KA 3KA 5KA 6 GENERIC ACTIVITIES INFRASTRUCT. Theme 1 KA 1 GEN. ACTIVITIES Theme 2 KA 4KA 1

19 DG XII - Life Sciences - Coordination 19 Implementation modalities Shared cost actions To obtain new knowledge likely to be useful either to develop new or significantly improve existing products, processes and services Demonstration projects To prove the technical viability of technologies that cannot be commercialised directly Combined projects To combine both a research and demonstration component Concerted actions To co-ordinate national RTD projects in order to exchange experience acquired, expand research efforts and disseminate results Support for networks To bring together manufacturers, users, universities and research centres concerned with the diffusion or transfer of innovation around a given scientific and technological objective SME specific measures To facilitate the participation of Small and Medium Enterprises in FP V Marie Curie Training fellowships To strengthen the human research potential in Europe

20 DG XII - Life Sciences - Coordination 20 A new concept : the cluster of projects Definition : a group of RTD projects providing the necessary critical mass to address a major objective within the thematic programme Objectives : to promote multidisciplinarity, maximise European added value and facilitate the optimisation of resources and the exploitation of results Modalities : A priori clusters can be submitted by linking several single RTD projects (RTD, demonstration, combined projects) Clusters can also be built a posteriori by bringing together several selected single RTD projects or adding a single RTD proposal to an existing cluster

21 DG XII - Life Sciences - Coordination 21 Proposal Evaluation NO GO Contribution to EU social objectives Community added value Economic development and S&T prospects GO Scientific excellence Management YES Eligibility NO

22 DG XII - Life Sciences - Coordination 22 Whats different from FP4? In FP4, one of the evaluation criteria was to consider whether or not proposals were in the scope of the scientific fields, as described in the work programme In FP5, this is replaced by whether or not proposals match the socio-economic objectives of the key action, as described in the work programme


Download ppt "Bruno Hansen Bruno Hansen DG XII - Life Sciences - Coordination Fifth Framework Programme for Research, Technological Development and Demonstration 1998-2002."

Similar presentations


Ads by Google